How Has The Varicose Veins Treatment Market Size Evolved Historically?
The varicose veins treatment market has seen considerable growth due to a variety of factors.
• In recent times, there has been a robust expansion in the market size of varicose veins treatment. It is estimated to rise from $1.99 billion in 2024 to $2.12 billion in 2025, projecting a compound annual growth rate (CAGR) of 6.7%.
The historical growth can be credited to an increase in sedentary habits, a rise in outpatient care, escalating cosmetic worries associated with varicose veins, a surge in preventative measures for varicose veins, and a higher acceptance of lasers.
What Does Future Hold for The Varicose Veins Treatment Market Size?
The varicose veins treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for varicose veins treatments will likely experience significant expansion in the coming years, predicting to reach $2.71 billion by 2029 with a CAGR of 6.4%.
Factors contributing to this growth during the forecasted period include an inclination towards less invasive surgical procedures, escalating obesity statistics, development in healthcare facilities, growth in disposable income, and heightened governmental expenditure on healthcare. Technological progress, AI integration, 3D imaging, advanced compression therapy, and combined therapies are among the major trends expected in the forecast period.
Which Drivers Are Accelerating Growth In The Varicose Veins Treatment Market?
The anticipated expansion of the varicose veins treatment market is due to the growing preference for minimally invasive procedures. Such procedures utilize specific surgical techniques that involve small incisions and specialized instruments, causing less tissue damage compared to traditional, open surgery. As a result, there is less pain, shorter recovery periods, and almost no scarring. The attractiveness of minimally invasive procedures is due to factors like quicker recovery times, better patient results, and the rising elderly population. These factors collectively improve patient safety, satisfaction, and healthcare efficiency. Techniques such as endovenous laser therapy (EVLT) or sclerotherapy are effective minimally invasive treatments for varicose veins. They ensure minimal discomfort, faster recovery, and fewer complications. According to The Aesthetic Society, a US-based plastic surgery and cosmetic medicine organization, Americans spent over $11.8 billion in 2022 on aesthetic procedures, a 2% increase from the prior year. So, it's clear that the growing demand for minimally invasive procedures is fueling the varicose veins treatment market's expansion.
What Is The Segmentation Of The Global Varicose Veins Treatment Market?
The varicose veins treatment market covered in this report is segmented –
1) By Product: Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices
2) By Procedure: Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation Or Stripping
3) End-User: Hospitals, Specialized Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Ablation Devices: Endovenous Laser Therapy (EVLT) Devices, Sclerotherapy Devices
2) By Radiofrequency Ablation Devices: Radiofrequency Catheters, RF Ablation Systems
3) By Laser Ablation Devices: Laser Fiber Optic Devices, Laser Venous Ablation Systems
Pre-Book The Varicose Veins Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Varicose Veins Treatment Market?
Prominent businesses in the varicose veins treatment market are prioritizing the development of cutting-edge solutions such as treatments that do not require anesthesia. These efforts aim to improve patient results, increase access to medical care, streamline the treatment monitoring process, and offer a more personalized approach to therapy. Anesthesia-free treatments allow medical procedures to be carried out without the use of anesthesia, resulting in increased safety, shorter recovery times, and heightened patient comfort. For instance, VVT MEDICAL Ltd., a medical device company headquartered in Israel, was approved in April 2024 by the Ministry of Food and Drug Safety in South Korea for its innovative ScleroSafe platform for minimally invasive varicose vein treatment. Utilizing a nonthermal, nontumescent (NT-NT) method, this platform removes the necessity for heat or tumescent anesthesia, guaranteeing a painless procedure that does not require anesthesia. The ScleroSafe platform, developed for both therapeutic and cosmetic objectives, emphasizes the comfort and effectiveness of the patient. It has earned several regulatory approvals, such as CE Mark accreditation and FDA 510(k) authorization, and adheres to Good Manufacturing Practices (GMP). These accomplishments establish ScleroSafe as a pioneering solution in the management of varicose veins.
Who Are the Key Players in the Varicose Veins Treatment Market?
Major companies operating in the varicose veins treatment market are include:
• Medtronic PLC
• Becton Dickinson and Company
• Boston Scientific Corporation
• BTG Limited
• Acibadem International Group
• Froedtert Health Incorporated
• Merit Medical Systems Incorporated
• uvahealth
• AngioDynamics Incorporated
• Medi USA Limited Partnership
• Dornier MedTech GmbH
• Sciton Incorporated
• Invera Medical Limited
• Biolitec AG
• Alma Lasers Limited
• Won Tech Company Limited
• F Care Systems S.A.
• Eufoton S.R.L.
• Vascular Solutions Incorporated
• Theraclion S.A.
• uGlow Med Spa
• Varicose Veins India
What are the Regional Insights into the Varicose Veins Treatment Market?
North America was the largest region in the varicose veins treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the varicose veins treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
